Polar Asset Management Partners Inc. Pacific Biosciences Of California, Inc. Transaction History

Polar Asset Management Partners Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$5.97 - $10.36 $3.05 Million - $5.29 Million	-510,200 Reduced 61.25%	322,800 $3.17 Million
Q3 2023 Nov 14, 2023	BUY	$8.23 - $13.93 $2.19 Million - $3.71 Million	266,300 Added 46.99%	833,000 $6.96 Million
Q2 2023 Aug 14, 2023	SELL	$9.97 - $14.05 $947,150 - $1.33 Million	-95,000 Reduced 14.36%	566,700 $7.54 Million
Q1 2023 May 15, 2023	BUY	$7.94 - $12.02 $5.25 Million - $7.95 Million	661,700 New	661,700 $7.66 Million
Q2 2022 Aug 15, 2022	SELL	$4.02 - $10.43 $1.92 Million - $4.97 Million	-476,500 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$8.43 - $20.9 $4.02 Million - $9.96 Million	476,500 New	476,500 $4.34 Million
Q3 2019 Nov 14, 2019	SELL	$4.99 - $6.16 $2.37 Million - $2.93 Million	-475,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$5.92 - $7.41 $2.25 Million - $2.82 Million	380,000 Added 400.0%	475,000 $2.87 Million
Q1 2019 May 15, 2019	BUY	$6.8 - $7.4 $646,000 - $703,000	95,000 New	95,000 $687,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

Stay updated on Polar Asset Management Partners Inc. with notifications on news.